Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity.

van de Veerdonk FL, Wever PC, Hermans MH, Fijnheer R, Joosten LA, van der Meer JW, Netea MG, Schneeberger PM.

J Infect Dis. 2012 Jul 15;206(2):197-201. doi: 10.1093/infdis/jis335. Epub 2012 Jun 11.

PMID:
22689912
2.

Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Luderer R, Kok M, Niesters HG, Schuurman R, de Weerdt O, Thijsen SF.

Mol Diagn. 2005;9(4):195-200.

PMID:
16392898
3.

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.

Cancer. 2004 Mar 15;100(6):1162-70.

4.

Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.

Färber I, Hinderer W, Rothe M, Lang D, Sonneborn HH, Wutzler P.

J Med Virol. 2001 Apr;63(4):271-6.

PMID:
11241457
6.

Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.

Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.

Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):130-7. Epub 2006 Sep 18.

PMID:
16979842
7.

Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man.

Francisci D, Sensini A, Fratini D, Moretti MV, Luchetta ML, Di Caro A, Stagni G, Baldelli F.

J Neurovirol. 2004 Dec;10(6):414-7.

PMID:
15765813
8.

Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.

Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stöckl E.

J Med Virol. 2005 Jan;75(1):54-8.

PMID:
15543583
9.

Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.

Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, Jabs WJ.

J Clin Microbiol. 2003 Dec;41(12):5419-28.

11.

[Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].

Yi B, Gu YL, Zong YS, Cheng WM, Ji MF.

Ai Zheng. 2009 Aug;28(8):822-6. Chinese.

PMID:
19664327
12.
13.

Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.

Sener AG, Afsar I, Pinar E.

J Virol Methods. 2009 Aug;159(2):300-2. doi: 10.1016/j.jviromet.2009.04.009. Epub 2009 May 3.

PMID:
19406156
14.

[Antibodies to the infective agents of opportunistic infections in blood of patients with hemoblastosis complicated with pneumonia].

Bosh'ian RE, Rybalkina TN, Karazhas NV, Ermakova TM, Galstian GM, Osmanov EA, Vorob'ev AA.

Zh Mikrobiol Epidemiol Immunobiol. 2006 Mar-Apr;(2):53-7. Russian.

PMID:
16758900
15.

A systematic study of Epstein-Barr virus serologic assays following acute infection.

Rea TD, Ashley RL, Russo JE, Buchwald DS.

Am J Clin Pathol. 2002 Jan;117(1):156-61.

PMID:
11789721
16.

Epstein-Barr virus in pediatric patients after renal transplantation.

Schwab M, Böswald M, Korn K, Ruder H.

Clin Nephrol. 2000 Feb;53(2):132-9.

PMID:
10711415
17.

Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.

Fachiroh J, Stevens SJ, Haryana SM, Middeldorp JM.

J Virol Methods. 2010 Oct;169(1):79-86. doi: 10.1016/j.jviromet.2010.07.001. Epub 2010 Jul 16.

PMID:
20621126
18.

Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile.

García T, Tormo N, Gimeno C, Navarro D.

J Infect. 2008 Oct;57(4):351-3. doi: 10.1016/j.jinf.2008.07.017. Epub 2008 Sep 11. No abstract available.

PMID:
18789535
19.

Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.

Bhaduri-McIntosh S, Landry ML, Nikiforow S, Rotenberg M, El-Guindy A, Miller G.

J Infect Dis. 2007 Feb 15;195(4):483-92. Epub 2007 Jan 10.

PMID:
17230407
20.

Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.

Haque T, Chaggar T, Schafers J, Atkinson C, McAulay KA, Crawford DH.

J Med Virol. 2011 Feb;83(2):311-6. doi: 10.1002/jmv.21953.

PMID:
21181928

Supplemental Content

Support Center